Week44, 2023
- **Viruses, illness, and deaths**: Influenza A(H1N1) was the most frequently reported virus. 3.0% of respiratory specimens tested positive for influenza. 0.09% of deaths were attributed to influenza. One pediatric death from the 2022-2023 season was reported this week; one pediatric death has been reported for the ongoing 2023-2024 season.

- **U.S. virologic surveillance**: Of the 192 viruses reported by public health labs, 77.1% were Influenza A and 22.9% were Influenza B. Among Influenza A subtyped, 90.6% were A(H1N1) and 9.4% were A(H3N2).

- **Cumulative hospitalization rate**: The overall cumulative hospitalization rate for the season is 1.2 per 100,000 population, significantly increasing compared to previous seasons for week 44 except for 2022-2023.

- **Trends of deaths attributed to influenza**: Influenza deaths remained stable at 0.09%.

- **Percentage of Influenza A and Influenza B**: Clinical labs reported 69.8% of positive specimens as Influenza A and 30.2% as Influenza B. Public health labs reported 77.1% as Influenza A and 22.9% as Influenza B.

- **Novel influenza virus like COVID-19**: No novel influenza viruses or SARS-CoV-2 mentioned impacting this season directly.

- **Vaccination trends**: CDC recommends everyone 6 months or older to receive a flu vaccine. Vaccination is emphasized as the best preventive measure.

- **Outpatient respiratory illness visits**: 2.9% of visits were for respiratory illness, at the national baseline, with upward trends in 8 of the 10 HHS regions. Regions 4 and 6 are above baselines.

- **Expectation of flu activity from CDC**: Flu activity is increasing, especially in the South Central, Southeast, and West Coast regions, with higher hospital admissions and respiratory illnesses expected.

- **Other key factors**: Hospitalizations for influenza are increasing nationwide. The contribution of multiple respiratory viruses, including RSV and influenza, to outpatient respiratory illness varies by region.